Go to page
 

Bibliographic Metadata

Title
Standardization of allergen products : 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard
AuthorHimly, M. ; Nandy, A. ; Kahlert, H. ; Thilker, M. ; Steiner, M. ; Briza, P. ; Neubauer, A. ; Klysner, S. ; van Ree, R. ; Buchheit, K.H. ; Vieths, S. ; Ferreira, F.
Published in
Allergy, Hoboken, 2015, Vol. 71, Issue 4, page 495-504
PublishedWiley, 2015
LanguageEnglish
Document typeJournal Article
ISSN1398-9995
URNurn:nbn:at:at-ubs:3-6495 Persistent Identifier (URN)
DOI10.1111/all.12824 
Restriction-Information
 The work is publicly available
Files
Standardization of allergen products [0.83 mb]
Links
Reference
Classification
Abstract (English)

BACKGROUND: The Biological Standardization Programme of the European Directorate for Quality of Medicines and Healthcare (EDQM) aims at the establishment of well-characterized reference standards based on recombinant allergens and validated assays for the quantification of major allergen content. The objective of this study was to examine the detailed physicochemical and immunological characterization of recombinant Phl p 5.0109, the second available allergen reference standard. METHODS: Recombinant Phl p 5.0109 PP5ar06007 was produced under GMP conditions and analyzed by an array of physicochemical and immunological methods for identity, quantity, homogeneity, and folding stability in bulk solution, as well as thermal denaturation, aggregation state, and biological activity when formulated for long-time storage. RESULTS: PP5ar06007 revealed as a highly homogeneous, monomeric, well-folded preparation of rPhl p 5.0109, as documented by mass spectrometry, SDS-PAGE, isoelectric focusing, size-exclusion chromatography with light scattering, circular dichroism, and infrared spectroscopy. Upon storage at +4C, PP5ar06007 retained the monomeric state for at least 2 months. A protein quantity of 1.56 0.03 mg/ml was determined by amino acid analysis in PP5ar06007, and its biological activity was shown to be comparable to natural Phl p 5 in terms of basophil activation and T-cell reactivity. CONCLUSIONS: Recombinant Phl p 5.0109 PP5ar06007 was characterized extensively at the physicochemical and immunological level. It revealed to be a highly stable, monomeric, and immunologically equivalent of its natural counterpart. PP5ar06007 is now available as European Pharmacopoeia allergen reference standard for grass pollen products.

Stats
The PDF-Document has been downloaded 15 times.
License
CC-BY-License (4.0)Creative Commons Attribution 4.0 International License